Search Within

Sujata Patil

Formats
  1. Meeting Abstract (278)
  2. Journal Article (230)
  3. Correspondence (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Biostatistics Service (511)
  2. Epidemiology and Biostatistics (511)
  3. Department of Medicine (363)
  4. Solid Tumor Oncology Division (358)
  5. Survivorship Research (323)
  6. Surgery (247)

More Groups

People
  1. Clifford Hudis (141)
  2. Larry Norton (97)
  3. Robert Motzer (93)
  4. Monica Morrow (83)
  5. Darren Feldman (81)
  6. Edi Brogi (65)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (24)
  5. 2020 (29)
  6. 2019 (31)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Annals of Surgical Oncology (67)
  3. Cancer Research (55)
  4. Cancer (23)
  5. Breast Cancer Research and Treatment (18)
  6. Clinical Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (172)
  2. Springer (92)
  3. American Association for Cancer Research (71)
  4. Elsevier Inc. (34)
  5. Wiley Blackwell (33)
  6. Oxford University Press (19)

More Publishers

Results (511)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
    Journal Article

    Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Cumulative imaging radiation exposure following breast-conservation therapy
    Journal Article

    Marti, J. L.; Dauer, L. T.; Stempel, M.; Patil, S.; Kaplan, J.; Montgomery, L. L.
    Annals of Surgical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib in patients (pts) with ER/PR-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Sparano, J. A.; Caravelli, J.; Patil, S.; Abbruzzi, A.; Hawke, R.; Bromberg, J.; Nonemaker, J.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Bowel dysfunction after sphincter-preserving surgery
    Meeting Abstract

    Temple, L. K.; Patil, S.; Paty, P.; Weiser, M. R.; Nash, G.; Guillem, J. G.; Goodman, K. A.; Wong, W. D.; Schrag, D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • TWiST analysis to estimate overall benefit for metastatic renal cell carcinoma (mRCC) patients (pts) treated in a phase III trial of sunitinib versus interferon-alfa (IFN-alpha)
    Meeting Abstract

    Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Pathologic features and outcomes of pregnancy-associated breast cancer (PABC): A case control study
    Meeting Abstract

    Murphy, C.; Mallam, D.; Stein, S.; Patil, S.; Howard, J.; Sklarin, N. T.; Gemignani, M.; Hudis, C.; Seidman, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Long-term responders to sunitinib therapy for metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Molina, A. M.; Jia, X.; Ginsberg, M. S.; Velasco, S.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Chang, J. C.; Abbruzzi, A.; Patil, S.; Modi, S.; Seidman, A. D.; Sklarin, N. T.; Norton, L.; Hudis, C.; Fornier, M. N.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Breast conservation (BCT) for DCIS: A prospective study of how MRI impacts management (MGMT)
    Meeting Abstract

    Marti, J. L.; Goldberg, J. I.; Patil, S.; Barbashina, V. V.; Giri, D. D.; Brennan, S.; Lee, C.; Vallejo, C.; Morris, E. A.; Van Zee, K. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers
    Meeting Abstract

    McArthur, H. L.; Mahoney, K.; Morris, P. G.; Patil, S.; Jacks, L. M.; Howard, J.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save